Chauhan, D., Singh, A., Brahmandam, M., Podar, K., Hideshima, T., Richardson, P., . . . Anderson, K. C. (2008). Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. American Society of Hematology.

Chauhan, Dharminder, Ajita Singh, Mohan Brahmandam, Klaus Podar, Teru Hideshima, Paul Richardson, Nikhil Munshi, Michael A. Palladino, and Kenneth C. Anderson. Combination of Proteasome Inhibitors Bortezomib and NPI-0052 Trigger in Vivo Synergistic Cytotoxicity in Multiple Myeloma. American Society of Hematology, 2008.

Chauhan, Dharminder, et al. Combination of Proteasome Inhibitors Bortezomib and NPI-0052 Trigger in Vivo Synergistic Cytotoxicity in Multiple Myeloma. American Society of Hematology, 2008.